FinScope · 테마Themes
바이오테크Biotech
암젠·버텍스·모더나 등 바이오테크 종목의 낙폭입니다. 임상 결과에 따라 변동성이 큽니다.Drawdowns for biotech names — Amgen, Vertex, Moderna and peers. Clinical outcomes drive high volatility.
| # | 티커Ticker | 이름Name | 현재 낙폭Current decline | 역대 최대낙폭Max drawdown |
|---|---|---|---|---|
| 1 | MRNA | Moderna, Inc. - Common Stock | −70.3% | −95.4% |
| 2 | HIMS | Hims & Hers Health, Inc. Class A Common Stock | −60.0% | −87.3% |
| 3 | BIIB | Biogen Inc. - Common Stock | −54.4% | −90.0% |
| 4 | DXCM | DexCom, Inc. - Common Stock | −49.0% | −94.6% |
| 5 | TECH | Bio-Techne Corp - Common Stock | −45.2% | −74.4% |
| 6 | ISRG | Intuitive Surgical, Inc. - Common Stock | −39.5% | −82.3% |
| 7 | CRL | Charles River Laboratories International, Inc. Common Stock | −39.3% | −78.2% |
| 8 | RVTY | Revvity, Inc. Common Stock | −37.5% | −92.4% |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. - Common Stock | −34.4% | −91.8% |
| 10 | INCY | Incyte Corporation - Common Stock | −20.4% | −98.5% |
| 11 | AMGN | Amgen Inc. - Common Stock | −15.0% | −78.0% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | −7.6% | −91.8% |
| 13 | IQV | IQVIA Holdings, Inc. Common Stock | −7.4% | −51.5% |
| 14 | GILD | Gilead Sciences, Inc. - Common Stock | −6.6% | −70.8% |
데이터 기준 2026-09-11 · 큐레이션된 테마 구성종목을 FinScope 실데이터로 정리했습니다(현재 낙폭 깊은 순). 종목 편입은 정보 제공용이며 투자 추천이 아닙니다. 수치는 매일 1회 갱신됩니다.Data as of 2026-09-11 · A curated list of each theme's constituents with FinScope's own data, sorted by current decline. Membership is informational, not a recommendation. Figures update once daily.